Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (8EQ)

Market Open
12 Jun, 10:33
XDUS XDUS
3. 44
+0.06
+1.7751%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
3.38
Previous Close
Add Transaction
Day Range
3.44 3.44
Year Range
2.52 5.25
Want to track 8EQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8EQ trading today higher at €3.44, an increase of 1.7751% from yesterday's close, completing a monthly decrease of -3.3708% or -€0.12. Over the past 12 months, 8EQ stock lost -18.8679%.
8EQ is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0.075%. On average, the company has fell short of earnings expectations by -0.0632%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

8EQ Chart

Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript

Seekingalpha | 1 month ago
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.09 per share a year ago.

Zacks | 1 month ago
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.07 per share a year ago.

Zacks | 3 months ago

Cytek Biosciences, Inc. (8EQ) FAQ

What is the stock price today?

The current price is €3.44.

On which exchange is it traded?

Cytek Biosciences, Inc. is listed on XDUS.

What is its stock symbol?

The ticker symbol is 8EQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Cytek Biosciences, Inc. ever had a stock split?

No, there has never been a stock split.

Cytek Biosciences, Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Wenbin Jiang CEO
XDUS Exchange
US23285D1090 ISIN
US Country
663 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cytek Biosciences, Inc. is a prominent cell analysis solutions provider that has marked its presence in the field of biomedical research and clinical applications through its advanced cell analysis tools. Initially established as Cytoville, Inc., the company underwent a name change to Cytek Biosciences, Inc. in August 2015, reflecting its refined focus and commitment towards innovative bioscience solutions. Since its foundation in 1992, Cytek has been headquartered in Fremont, California, evolving into a key player that caters to the needs of pharmaceutical and biopharma companies, academic research centers, and clinical research organizations globally. The company boasts a comprehensive distribution network, with a direct sales force and support organizations spanning North America, Europe, China, and the Asia-Pacific, alongside distributors or sales agents covering European, Latin American, and the Middle Eastern countries.

Products and Services

Cytek Biosciences, Inc. offers a wide array of products and services designed to advance the field of cell analysis:

  • Aurora and Northern Lights Systems: These spectrum flow cytometers are instrumental in delivering precise cell analysis. They leverage the fluorescence signatures from multiple lasers to distinctly identify fluorescent tags on single cells, facilitating a comprehensive analysis.
  • Aurora Cell Sorter System: Utilizing full spectrum profiling technology, this system enhances cell analysis applications by effectively sorting and profiling cells.
  • Aurora CS Systems: These systems further build on the capabilities of the Aurora line, incorporating cutting-edge technologies for advanced cell analysis functions.
  • Amnis ImageStream Imaging Flow Cytometers: By combining flow cytometry and imaging technologies, these systems offer detailed insights into cell characteristics and behaviors.
  • Guava Muse Cell Analyzers: These analyzers provide a compact and straightforward solution for cell analysis, suitable for smaller laboratories or specific research needs.
  • Guava EasyCyte Flow Cytometers: Known for their user-friendly interface and efficient performance, these cytometers support diverse cell analysis applications.
  • Orion Reagent Cocktail Preparation Systems: These systems are designed to simplify the preparation of reagent cocktails, ensuring accuracy and consistency in cell analysis experiments.
  • Reagents and Kits: Cytek offers a range of cFluor reagents, which are fluorochrome-conjugated antibodies designed to identify cells of interest with high specificity on its instruments. Additionally, the company provides a 25-color immunoprofiling assay, offering a turnkey solution for identifying major human immune subpopulations.
  • Automated Micro-Sampling System and Automated Sample Loader System: These automated loaders are designed to integrate seamlessly into the Aurora and Northern Lights systems, streamlining the sample loading process for high-throughput applications.
  • SpectroFlo Software: This software delivers an intuitive workflow from quality control to data analysis for the Aurora and Northern Lights systems, enhancing user experience and efficiency.

In addition to these pioneering products, Cytek Biosciences, Inc. emphasizes customer support, providing comprehensive tools and assistance to ensure the success of its clients' projects.

Contact Information

Address: 47215 Lakeview Boulevard
Phone: 877 922 9835